Today: 19 May 2026
Browse Category

NSE:HCC 2 December 2025 - 5 December 2025

HCC Rights Issue Record Date, Rupee Rebounds After Record Low, and Universal Office Automation’s Trend: Key Market Stories on 5 December 2025

HCC Rights Issue Record Date, Rupee Rebounds After Record Low, and Universal Office Automation’s Trend: Key Market Stories on 5 December 2025

Hindustan Construction Company’s ₹1,000 crore rights issue takes effect today, offering shares at ₹12.50, over 50% below market price and increasing share count by 44% if fully subscribed. The rupee rebounded after breaching ₹90 per dollar. The RBI kept the repo rate steady at 5.50%. Universal Office Automation tried to recover after a sharp fall.
5 December 2025
·
CAMS Stock Split, Apis India 24:1 Bonus, HUL Demerger, Panorama Bonus & HCC Rights: All Key Corporate Actions on 5 December 2025

CAMS Stock Split, Apis India 24:1 Bonus, HUL Demerger, Panorama Bonus & HCC Rights: All Key Corporate Actions on 5 December 2025

India’s equity market saw major corporate actions on 5 December 2025, including a 1:5 stock split by CAMS, a 24:1 bonus issue by Apis India, and the HUL–Kwality Wall’s demerger. Panorama Studios International issued a 5:2 bonus, and HCC set a ₹1,000 crore rights issue record date. Multiple ex-dates concentrated trading activity and price adjustments on Dalal Street.
5 December 2025
·····
Hindustan Construction Company (HCC) Jumps on ₹1,000 Crore Rights Issue: Share Price Today, Key Dates, and 2025–26 Outlook

Hindustan Construction Company (HCC) Jumps on ₹1,000 Crore Rights Issue: Share Price Today, Key Dates, and 2025–26 Outlook

Hindustan Construction Company shares jumped 11–12% to ₹26.5–₹27 on the NSE midday after its board approved a ₹1,000 crore rights issue at ₹12.50 per share, a 54% discount to today’s high. Trading volumes surged into the tens of millions. The rights issue opens 12 December, with a record date set for 5 December. Despite the rally, HCC stock remains down over 37% year-on-year.
2 December 2025
·

Stock Market Today

  • Citi Raises Intel Stock Price Target to $130 on Agentic AI-Driven CPU Demand
    May 19, 2026, 6:58 AM EDT. Citi analyst Atif Malik raised Intel's price target to $130 from $95, projecting a 37% increase driven by a new CPU market model targeting 2030. Citi expects the server CPU market to reach $132 billion by 2030, fueled by growing demand for CPUs in agentic AI-AI software acting autonomously, requiring intensive CPU usage. Intel's strong position in data center server CPUs and its ASIC business, including Mount Evans infrastructure processing units used by Google and Anthropic, underpin this bullish outlook. Intel is reportedly sold out on server CPUs for 2026 and considering price hikes of 10-15%, indicating robust demand beyond cyclical trends, supporting Citi's upgraded forecast.

Latest articles

Standard Chartered’s Push Into AI May Cut 7,000 Jobs as Bank Looks for 18% Returns

Standard Chartered’s Push Into AI May Cut 7,000 Jobs as Bank Looks for 18% Returns

19 May 2026
Standard Chartered will cut over 7,000 jobs by 2030 and aims for an 18% return on tangible equity, focusing on AI and automation to boost efficiency. The bank reported record Q1 operating income of $5.9 billion and profit before tax of $2.5 billion. Job cuts will mainly affect corporate and support roles in hubs like Bengaluru, Tianjin, and Warsaw. The bank seeks to attract $200 billion in new wealth by 2028.
AEP Stock Moves as 13F Filings Add More Questions

AEP Stock Moves as 13F Filings Add More Questions

19 May 2026
Institutional holdings in American Electric Power fell by March 31, with Northwestern Mutual Wealth Management, Allworth Financial, and Lockheed Martin Investment Management all reporting smaller stakes than at year-end. AEP raised its five-year capital plan to $78 billion this month, citing rising demand from data centers and industry. The company priced a 23.5 million share offering at $127 each after reporting first-quarter operating earnings of $1.64 per share.

Popular

Sunshine Biopharma Shares Volatile After $6M Deal, 50-Cent Mark in Focus

Sunshine Biopharma Shares Volatile After $6M Deal, 50-Cent Mark in Focus

19 May 2026
Sunshine Biopharma shares surged as much as 516% before settling up 78% at $0.51 in heavy after-hours Nasdaq trading Monday, following a $6 million public offering priced at $0.50 per unit. More than 436 million shares changed hands, far exceeding the company’s 5 million shares outstanding. The deal includes 12 million units with warrants, raising dilution concerns. Closing is expected around May 19.
Go toTop